Business
Attending JPMorgan Conference & Biotech Showcase
ImmuPharma PLC announced that its CEO, COO, and CSO will attend the JP Morgan Conference and Biotech Showcase in San Francisco from January 12-14, 2026, to engage with global biopharma companies and investors at these premier partnering events. Disclaimer*
About this update from Immupharma Plc
[{"type":"text","content":"\n\nRNS REACH |6 JANUARY 2026\n \n\n \nImmuPharma PLC\n(\"ImmuPharma\" or the \"Company\")\n \nIMMUPHARMA AT JP MORGAN CONFERENCE & BIOTECH SHOWCASE™\n12-14 January 2026 | San Francisco\n \nImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, announces that Tim McCarthy, CEO, Dr Tim Franklin, COO, and Dr Sebastien Goudreau, CSO, will be attending both the JP Morgan Conference and the Biotech Showcase from 12-14 January 2026, in San Francisco, USA.\n \nThe JP Morgan conference and Biotech Showcase are annual premier partnering events, designed to provide biotechnology companies with the opportunity to present to and connect with global Biopharma companies and investors.\n \nEnd\n \n\n\n\n\nFor further information please contact:\n \n\n\n\n\nImmuPharma PLC (www.immupharma.co.uk)\nTim McCarthy, Chief Executive Officer\nLisa Baderoon, Head of Investor Relations\n\n\n+44 (0) 207 206 2650\n \n+ 44 (0) 7721 413496\n \n \n\n\n\n\n\n\n\n\n\n\n\n\nSPARK Advisory Partners Limited (NOMAD)\nNeil Baldwin\n \nStanford Capital Partners (Joint Broker)\nPatrick Claridge, Bob Pountney\n \nSI Capital (Joint Broker)\nNick Emerson\n \n\n\n+44 (0) 203 368 3550\n \n \n+44 (0) 20 3650 3650\n \n \n+44 (0) 1483 413500\n \n \n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n \n \nNotes to Editors\nAbout ImmuPharma PLC\n \nImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company's portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives.\n \nFor additional information about ImmuPharma please visit www.immupharma.co.uk\n \nImmuPharma's LEI (Legal Entity Identifier) code : 213800VZKGHXC7VUS895.\n \n \nAbout JP Morgan Healthcare Conference\n \nThe J.P. Morgan Healthcare Conference 2026 is the industry's premier investment symposium. It draws over 8,000 attendees including pharma/biotech executives, investors, startups, analysts, and policymakers for strategic discussions and dealmaking.\n \nAbout Biotech Showcase\n \nBiotech Showcase in San Francisco is an investor‑focused partnering conference held each January alongside JP Morgan Healthcare Conference week. It is designe...